merger acquisition M&A business

Private equity in cardiology: 4 key takeaways from a 10-year analysis

Tracking private equity acquisitions can be challenging, but that didn't stop researchers from exploring the last decade of activity in cardiology. "It will be critical to monitor the effects on procedural utilization, quality and outcomes for patients with CVD,” the group wrote. 

Biolimus A9 Coated Balloon from BioAscend

In-stent restenosis after PCI: New biolimus-coated balloon non-inferior to paclitaxel devices

A new study of nearly 300 PCI patients suggests biolimus-coated balloons could provide significant value to interventional cardiologists in the years ahead.  

Denise Busman from MedAxoim explains importance of the business management model in cardiology departments. She presented in a business of cardiology session at ACC 2024. #Medaxoim #ACC #ACC2024

Why your cardiology department's leadership structure matters

The way a cardiology department's management is organized can have a direct impact on physician satisfaction and patient care. "Without good governance and leadership, nothing else matters," one expert said. 

Cardiologist heart

New editor shares vision for ACC’s flagship journal: ‘Chasing impact, not impact factor’

Veteran cardiologist Harlan M. Krumholz, MD, has a long history in medical research as both an author and an editor. He and his team want to review manuscripts quickly and publish a wide variety of voices.

Vivek Reddy, MD, Director, Cardiac Arrhythmia Service, and the Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, at Mount Sinai in New York, was involved in most of the late-breaking pulsed field ablation (PFA) trials at the Heart Rhythm Society (HRS) 2024 meeting. He offers an overview of the new data presented and his observations from using PFA. #HRS24 #HRS2024 #PFA #EPeeps

The future of electrophysiology: Reviewing key trends in PFA

Vivek Reddy, MD, was involved in most of the late-breaking pulsed field ablation trials at Heart Rhythm 2024. He spoke to Cardiovascular Business at the conference about those trials and what they mean going forward.

Thumbnail

1.6 million excess Black deaths owed to inequities in cardiac care, JACC report card reveals

A JACC report card highlights excess cardiovascular mortality among Black Americans and "persistent and tragic inequities" in cardiovascular care.

The ASNC team at the 2024 AMA meeting, Georgia Lawrence, JD, ASNC director of regulatory affairs; Suman Tandon, MD, FASNC, delegate to the AMA HOD and cardiac imager at NYU Langone; and Kathy Flood, ASNC CEO. #AMA #AMA24 #AMA2024 #AMAHOD #ASNC

ASNC supports AMA effort to limit use of AI in prior authorization decisions

The American Society of Nuclear Cardiology (ASNC) supports an AMA policy that condemns the use AI to make prior authorization decisions rather than a doctor or clinician.

How long do wearable cardiac monitors record data?

Long-term continuous monitoring (LTCM) wearable devices now make up 40% or more of the remote ECG monitoring market due to ease of use and collection of more data.